EFMH
ONC

E Fund Management (HK)’s BeOne Medicines Ltd ONC Stock Holding History

E Fund Management (HK)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,961
Closed -$4.31M – 33
2022
Q3 		$4.31M Sell
31,961
-258
-0.8% -$44.3K 3.42% 9
2022
Q2 		$5.21M Buy
32,219
+4,718
+17% +$737K 3.6% 9
2022
Q1 		$5.07M Buy
27,501
+15,929
+138% +$3.39M 3.22% 12
2021
Q4 		$3.13M Buy
+11,572
New +$3.91M 1.74% 10
2021
Q2 		$4.03M Sell
11,747
-434
-4% -$144K 2.51% 12
2021
Q1 		$4.24M Buy
12,181
+181
+2% +$59.9K 1.37% 14
2020
Q4 		$3.1M Buy
+12,000
New +$3.3M 1.07% 16

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

E Fund Management (HK)'s ONC Position: Q4 2022 in Review

E Fund Management (HK) sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 31,961 shares — an estimated $4.31M sold.

E Fund Management (HK) first reported a position in ONC in Q4 2020 and held it in 7 quarters. The position peaked at $5.21M in Q2 2022. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • E Fund Management (HK) reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • E Fund Management (HK) sold 31,961 BeOne Medicines Ltd shares in Q4 2022, an estimated $4.31M.
  • E Fund Management (HK) first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 7 quarters.
  • E Fund Management (HK)'s BeOne Medicines Ltd position peaked at $5.21M in Q2 2022.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on E Fund Management (HK)'s 13F filing for Q4 2022, filed 1 Feb 2023.